ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.750,92
-0,31%
S&P 500
5.308,13
0,09%
US Dollar vs BRL
5,1046
0,02%
Bitcoin
69.281,55
4,54%
Brent Oil
83,48
-0,14%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Forma Therapeutics Holdings Inc (FMTX)

  7. Forma Therapeutics Holdings Inc (FMTX) Notícias

FMTX

Forma Therapeutics (FMTX)

Forma Therapeutics Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FMTX
DataHoraFonteTítuloCódigoCompanhia
14/02/202310:34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
24/10/202212:23Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202217:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202210:25Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202210:19Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202210:00Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FMTXForma Therapeutics Holdings Inc
14/10/202209:49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FMTXForma Therapeutics Holdings Inc
07/10/202209:17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
30/09/202210:00Business WireSickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the DiseaseNASDAQ:FMTXForma Therapeutics Holdings Inc
15/09/202218:26Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:FMTXForma Therapeutics Holdings Inc
15/09/202218:22Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:FMTXForma Therapeutics Holdings Inc
02/09/202217:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FMTXForma Therapeutics Holdings Inc
01/09/202218:23Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:FMTXForma Therapeutics Holdings Inc
01/09/202211:19Dow Jones NewsForma Therapeutics Shares Surge on Takeover by Novo NordiskNASDAQ:FMTXForma Therapeutics Holdings Inc
01/09/202209:52Dow Jones NewsNovo Nordisk to Buy Forma Therapeutics for $1.1 BillionNASDAQ:FMTXForma Therapeutics Holdings Inc
01/09/202209:00Business WireNovo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disordersNASDAQ:FMTXForma Therapeutics Holdings Inc
23/08/202207:15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Forma Therapeutics Holdings (FMTX)NASDAQ:FMTXForma Therapeutics Holdings Inc
05/08/202217:50Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FMTXForma Therapeutics Holdings Inc
05/08/202217:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FMTXForma Therapeutics Holdings Inc
05/08/202208:00Business WireForma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:FMTXForma Therapeutics Holdings Inc
05/08/202200:21TipRanksForma Therapeutics Holdings (FMTX) Receives a Buy from SVB SecuritiesNASDAQ:FMTXForma Therapeutics Holdings Inc
02/08/202217:01PR Newswire (US)Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid LeukemiaNASDAQ:FMTXForma Therapeutics Holdings Inc
29/07/202208:05Business WireForma Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 5, 2022NASDAQ:FMTXForma Therapeutics Holdings Inc
12/07/202217:24Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FMTXForma Therapeutics Holdings Inc
12/07/202208:05Business WireForma Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:FMTXForma Therapeutics Holdings Inc
30/06/202208:05Business WireForma Therapeutics Announces Appointment of New Executive Team MembersNASDAQ:FMTXForma Therapeutics Holdings Inc
10/06/202208:22Business WireForma Therapeutics Announces Presentations at Upcoming Hematology ConferencesNASDAQ:FMTXForma Therapeutics Holdings Inc
09/06/202207:25TipRanksH.C. Wainwright Sticks to Its Buy Rating for Forma Therapeutics Holdings (FMTX)NASDAQ:FMTXForma Therapeutics Holdings Inc
03/06/202217:13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FMTXForma Therapeutics Holdings Inc
03/06/202208:05Business WireForma Therapeutics to Present at the Jefferies Healthcare ConferenceNASDAQ:FMTXForma Therapeutics Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:FMTX

Seu Histórico Recente

NASDAQ
AAXQDXX
BofA Finance LLC Issuer ...
NASDAQ
AAYPBXX
Bank of Montreal Capped ...
EU
BPCGA
BPCE Bpcefrn25may28
NASDAQ
AAZFJXX
Bank of Montreal Capped ...
COIN
MAFIAUSD
Crypto Mafia
ASX
NSMN
North Stawell Minerals
USOTC
LNDZF
Evome Medical Technologies (PK)
EU
XS1285080740
ABN Amro Bank NV 4.37% C...
AMEX
XFEB
FT Vest US Equity Enhanc...
BIT
S31942
Societe Generale Effekten
LSE
FB94
Permanent .73 A
LSE
QU64
Mor.st.fin 25
TG
MIN
Synlogic
EU
R693S
R693S
LSE
12LR
Stand.chat R
EU
FR0128351311
CA Consumer Finance Cacf...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados